Literature DB >> 30001118

Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Lee E Dunlap1, Anne M Andrews2, David E Olson1,3,4.   

Abstract

Better known as "ecstasy", 3,4-methylenedioxymethamphetamine (MDMA) is a small molecule that has played a prominent role in defining the ethos of today's teenagers and young adults, much like lysergic acid diethylamide (LSD) did in the 1960s. Though MDMA possesses structural similarities to compounds like amphetamine and mescaline, it produces subjective effects that are unlike any of the classical psychostimulants or hallucinogens and is one of the few compounds capable of reliably producing prosocial behavioral states. As a result, MDMA has captured the attention of recreational users, the media, artists, psychiatrists, and neuropharmacologists alike. Here, we detail the synthesis of MDMA as well as its pharmacology, metabolism, adverse effects, and potential use in medicine. Finally, we discuss its history and why it is perhaps the most important compound for the future of psychedelic science-having the potential to either facilitate new psychedelic research initiatives, or to usher in a second Dark Age for the field.

Entities:  

Keywords:  3,4-methylenedioxymethamphetamine; MDMA; empathogen; entactogen; psychedelic

Mesh:

Substances:

Year:  2018        PMID: 30001118      PMCID: PMC6197894          DOI: 10.1021/acschemneuro.8b00155

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  249 in total

1.  Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

Authors:  William E Fantegrossi; Tomek Godlewski; Rachel L Karabenick; Jermaine M Stephens; Thomas Ullrich; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2003-02-01       Impact factor: 4.530

Review 2.  The background and chemistry of MDMA.

Authors:  A T Shulgin
Journal:  J Psychoactive Drugs       Date:  1986 Oct-Dec

Review 3.  Can MDMA play a role in the treatment of substance abuse?

Authors:  Lisa Jerome; Shira Schuster; B Berra Yazar-Klosinski
Journal:  Curr Drug Abuse Rev       Date:  2013-03

Review 4.  Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational 'ecstasy'.

Authors:  Andrew C Parrott
Journal:  Behav Pharmacol       Date:  2016-12       Impact factor: 2.293

Review 5.  Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.

Authors:  Rosario Moratalla; Amit Khairnar; Nicola Simola; Noelia Granado; Jose Ruben García-Montes; Pier Francesca Porceddu; Yousef Tizabi; Giulia Costa; Micaela Morelli
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

6.  Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.

Authors:  Joseph J Palamar; Pia M Mauro; Benjamin H Han; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2017-10-06       Impact factor: 4.492

7.  3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors.

Authors:  R A Lyon; R A Glennon; M Titeler
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 8.  Development of a rational scale to assess the harm of drugs of potential misuse.

Authors:  David Nutt; Leslie A King; William Saulsbury; Colin Blakemore
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

9.  The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.

Authors:  R L Carhart-Harris; M B Wall; D Erritzoe; M Kaelen; B Ferguson; I De Meer; M Tanner; M Bloomfield; T M Williams; M Bolstridge; L Stewart; C J Morgan; R D Newbould; A Feilding; H V Curran; D J Nutt
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 5.176

10.  Psychedelics Promote Structural and Functional Neural Plasticity.

Authors:  Calvin Ly; Alexandra C Greb; Lindsay P Cameron; Jonathan M Wong; Eden V Barragan; Paige C Wilson; Kyle F Burbach; Sina Soltanzadeh Zarandi; Alexander Sood; Michael R Paddy; Whitney C Duim; Megan Y Dennis; A Kimberley McAllister; Kassandra M Ori-McKenney; John A Gray; David E Olson
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423

View more
  12 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Optogenetic Stimulation of Midbrain Dopamine Neurons Produces Striatal Serotonin Release.

Authors:  Merel Dagher; Katie A Perrotta; Sara A Erwin; Ayaka Hachisuka; Rahul Iyer; Sotiris C Masmanidis; Hongyan Yang; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2022-03-21       Impact factor: 5.780

3.  Psychedelic Microdosing: Prevalence and Subjective Effects.

Authors:  Lindsay P Cameron; Angela Nazarian; David E Olson
Journal:  J Psychoactive Drugs       Date:  2020-01-23

4.  Psychedelic-inspired drug discovery using an engineered biosensor.

Authors:  Chunyang Dong; Calvin Ly; Lee E Dunlap; Maxemiliano V Vargas; Junqing Sun; In-Wook Hwang; Arya Azinfar; Won Chan Oh; William C Wetsel; David E Olson; Lin Tian
Journal:  Cell       Date:  2021-04-28       Impact factor: 41.582

Review 5.  MDMA to Treat PTSD in Adults.

Authors:  Dustin Latimer; Michael D Stocker; Kia Sayers; Jackson Green; Adam M Kaye; Alaa Abd-Elsayed; Elyse M Cornett; Alan D Kaye; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-06-01

6.  Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics.

Authors:  David E Olson
Journal:  J Exp Neurosci       Date:  2018-09-19

7.  Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.

Authors:  Lindsay P Cameron; Charlie J Benson; Brian C DeFelice; Oliver Fiehn; David E Olson
Journal:  ACS Chem Neurosci       Date:  2019-03-04       Impact factor: 4.418

8.  Dopamine receptor antagonists effects on low-dimensional attractors of local field potentials in optogenetic mice.

Authors:  Sorinel A Oprisan; Xandre Clementsmith; Tamas Tompa; Antonieta Lavin
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

Review 9.  Substance-Induced Psychoses: An Updated Literature Review.

Authors:  Alessio Fiorentini; Filippo Cantù; Camilla Crisanti; Guido Cereda; Lucio Oldani; Paolo Brambilla
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

10.  Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA.

Authors:  Jay B Nair; Linda Hakes; Berra Yazar-Klosinski; Kathryn Paisner
Journal:  ACS Omega       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.